Dr Denis Donohue of the FDA asked the pharmaceutical companies to stop using blood collected from donors likely to have high levels of antibodies to hepatitis.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation